跳至主要内容
临床试验/EUCTR2005-004885-18-IT
EUCTR2005-004885-18-IT进行中(未招募)不适用

Evaluation of febrile event during emopoietic progenitor cells aferesi post chemotherapy treatment in patients affected by multiple myeloma. - ND

AZIENDA OSPEDALIERA PISANA0 个研究点目标入组 68 人开始时间: 2006年4月21日最近更新:
适应症
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
68

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -Multiple myeloma diagnosis -Time from prymary chemotherapy to HD chemotherapy between 30/60 days. -HCV HBSAG negative.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Document or probabily infections. -Cardiological disease -Other medical conditions uncontrolled.

研究者

发起方
AZIENDA OSPEDALIERA PISANA

相似试验